TZDs, GLP-1 agonist may worsen diabetic retinal disease

Two classes of drugs commonly used to treat type 2 diabetes and theoretically prevent its complications may instead be associated with progression of diabetic retinal disease, said investigators in two studies presented here.

Related Videos
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Beth Lown, MD
Related Content

Health care costs increasing physical and mental problems for patients

June 7th 2023

How scientific denialism undermines public health

March 9th 2023

Federal court to consider Medicare drug price negotiations of the Inflation Reduction Act

June 7th 2023

It's not just money: why disparities in access to health care have been growing

December 14th 2022

Smoking cessation: The time is now

June 7th 2023

Nurses face widespread bias, study finds

June 6th 2023

Health care costs increasing physical and mental problems for patients

June 7th 2023

How scientific denialism undermines public health

March 9th 2023

Federal court to consider Medicare drug price negotiations of the Inflation Reduction Act

June 7th 2023

It's not just money: why disparities in access to health care have been growing

December 14th 2022

Smoking cessation: The time is now

June 7th 2023

Nurses face widespread bias, study finds

June 6th 2023

Health care costs increasing physical and mental problems for patients

June 7th 2023

How scientific denialism undermines public health

March 9th 2023

Federal court to consider Medicare drug price negotiations of the Inflation Reduction Act

June 7th 2023

It's not just money: why disparities in access to health care have been growing

December 14th 2022

Smoking cessation: The time is now

June 7th 2023

Nurses face widespread bias, study finds

June 6th 2023
© 2023 MJH Life Sciences

All rights reserved.